Acoramidis linked to improved outcomes versus tafamidis in real-world ATTR-CM study
An independent study of U.S. electronic health records associated acoramidis with significantly improved clinical outcomes versus tafamidis in ATTR-CM.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.